Clinical Trial Update: Study to Evaluate Phenobarbital Sodium Injection for the Treatment of Neonatal Seizures [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating phenobarbital sodium injection for neonatal seizures has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Seizures

Drugs mentioned

• Phenobarbital sodium injection (phenobarbital sodium injection)

Snippet

Sponsor: PharPoint Research, Inc. | Conditions: Neonatal Seizure | Phase 3 | Status: WITHDRAWN